Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
CSW Industrials declared a quarterly cash dividend of $0.30 per share, payable on August 14, 2026, for shareholders of record as of July 31, 2026. The company operates in diversified industrial sectors including HVAC/R, plumbing, electrical, and other specialized industrial markets.
Arch Capital (ACGL) looks attractively cheap on headline multiples, but the market is starting to price flatter reinsurance renewals. With shares near $100 and momentum losing steam, we prefer a tactical short into mid-term weakness: enter at $100.03, target $88.00, stop $106.00. This is a mid-term (45 trading days) trade sized for investors who ac…
Ocean Power Technologies announced that its WAM-V unmanned surface vehicle maritime drone technology has been selected by the U.S. Government for further assessment following a competitive capability review. This selection, while not a direct contract, signifies increased engagement and interest in OPT's autonomous maritime capabilities, positionin…
Q32 Bio's recent program developments and corporate actions have shifted the risk profile from pure early-stage binary to one with tangible commercial optionality and cash support. I outline a mid-term trade plan that captures upside to program re-rating while limiting downside with a defined stop.
SL Science Holding Limited announced successful presentation of preclinical data demonstrating the potent anti-glioblastoma effects of their novel gamma delta T-cell therapy at the 2026 World Congress of Basic and Clinical Pharmacology. The research, conducted in collaboration with Taipei Medical University, JY BioMed, and HeXun Biosciences, showed…
Nano Dimension Ltd. announced the termination of its corporate headquarters lease, originally set to expire in 2031, resulting in approximately $25 million net cash savings after lease termination payment. This move is part of broader cost-saving initiatives following the sale of MarkForged, aiming to strengthen the company's financial position by …
Sunrise Realty Trust, a Nasdaq-listed commercial real estate lender focused on transitional CRE projects in the Southern United States, announced its second quarter 2026 earnings release date and will host a webcast conference call for investors on August 6, 2026.
General Fusion Group Ltd. announced its recent listing on Nasdaq under the ticker GFUZ and its celebration ringing the Nasdaq Opening Bell, marking it as the first publicly listed fusion energy company. The company highlighted its Magnetized Target Fusion (MTF) technology and the development of its LM26 fusion demonstration machine, aiming to achie…
Playtika Holding Corp. announced that it will release its financial results for the second quarter of 2026 on August 6, 2026, before U.S. markets open. The company will also host a conference call on the same day to discuss these results.
NANO Nuclear Energy Inc. (NASDAQ: NNE) has joined the Virginia Nuclear Energy Consortium (VNEC) to collaborate on advancing nuclear energy innovation, deployment, research, and workforce initiatives in Virginia, a state experiencing rapid growth in power demand, especially from data centers. As a part of VNEC, NANO Nuclear aims to leverage Virginia…
Advanced Flower Capital Inc. (Nasdaq: AFCG) will release its second quarter 2026 financial results on August 13, 2026, prior to market open. Management will host a webcast and conference call to discuss results, aimed at providing investors with insight into the company's performance. The company focuses on providing flexible credit solutions to lo…
Abacus Global Management, a NYSE-listed financial services firm specializing in alternative asset management, announced it will release its Q2 2026 financial results after market close on August 6, 2026. The company will host a conference call and webcast to discuss the results the same day, providing investors with an opportunity to engage and ass…
Enovis Corporation, a medical technology company listed on NYSE under the ticker ENOV, has scheduled a conference call and webcast on August 6th, 2026 to discuss its second quarter financial results. The event will be accessible through the company's investor relations website, with details for investors to participate provided. This announcement s…
Damora Therapeutics, a biotechnology company focused on treatments for blood disorders, announced its redomestication from Delaware to the Cayman Islands effective July 16, 2026. The company's shares will continue to trade on Nasdaq under the symbol DMRA with a new CUSIP. The redomestication does not change the company's operations or management.
Amneal Pharmaceuticals has obtained FDA approval for new strengths and vial sizes of its iohexol injection, a radiographic contrast agent used in various imaging procedures. The expanded portfolio is set to meet most of the U.S. iohexol injection market demand, positioning Amneal as a key player in complex injectables and hospital products. The com…
VisionWave Holdings announces filing of a provisional patent application for GhostSight™, a hybrid passive radar system that combines environmental RF signals with distributed cooperative illuminators, enhanced by AI/ML fusion for improved detection, classification, and situational awareness across defense and security sectors.
Ecolab is a durable, cash-generative leader in water, hygiene and thermal-management services. Recent results show low-single-digit organic growth, solid margin expansion and healthy free cash flow. The $4.75B CoolIT acquisition gives Ecolab direct exposure to the fast-growing AI data-center cooling market, adding near-term revenue and long-term op…
Grindr is showing durable paid-user strength and profitable growth that the market is under-appreciating. With revenue up ~28% y/y to $440M in 2025 and net income returning to $95M, the stock at $15.76 is offering asymmetric upside toward $20 while still managing meaningful downside risk from leverage and governance noise. We upgrade the rating and…
FedEx's freight unit sits with spare capacity while overall freight demand shows signs of recovery. At $318, the stock trades at ~17x earnings with solid free cash flow and room for margin recovery if pricing normalizes. This trade targets a re-test of the $345 area over the next 45 trading days with a disciplined stop below $298.
Edible Garden AG Incorporated announced that Wakefern Food Corp. is expanding the Garden Starters pallet display program with a midsummer promotional event at participating ShopRite locations. The program features USDA Organic Certified living herb plants to meet rising consumer demand for fresh, sustainable produce and promote home gardening. Edib…
Clearmind Medicine Inc., trading as CMND on Nasdaq, applauds recent developments by multiple U.S. federal agencies including FDA, HHS, VA and others, which support the advancement of psychedelic-based therapies for neuropsychiatric and addiction disorders. The company highlights regulatory progress such as final FDA guidance on psychedelic clinical…
Streamex Corp. (NASDAQ: STEX) announced the fourth monthly yield distribution for GLDY, its yield-bearing gold token, covering June 2026. The yield, generated through an institutional gold leasing program, is currently at an annualized rate of 3.9%, providing GLDY holders with monthly additional tokens as dividends. This yield outperforms tradition…
Camping World Holdings, Inc., the largest US retailer of RVs and related products, announced the release date for its second quarter 2026 financial results. The earnings will be released after market close on July 29, 2026, followed by a conference call on July 30 to discuss the results with investors and analysts.
Artiva Biotherapeutics announced the approval of inducement grants of 288,800 restricted stock units for 17 new employees under its 2025 Inducement Plan. These grants are intended to attract talent to support the company’s development of cell therapies targeting autoimmune diseases, including ongoing clinical trials for AlloNK therapy.
Evaxion A/S will present three-year clinical efficacy data from its phase 2 trial of personalized cancer vaccine EVX-01 at the upcoming ESMO Congress 2026. The data includes insights on EVX-01's durability and effectiveness as a stand-alone treatment for advanced melanoma. Previous two-year results showed high response rates and sustained immune re…
